Skip to content

Author

Saurabh Srivastava

We have 7 of 171 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Electrospun silk sericin-poly(lactic acid) coaxial nanofiber scaffold for esmolol and ferulic acid co-delivery in expedited diabetic wound healing.

Diabetic foot ulcers (DFUs) are chronic, infection-prone wounds that heal poorly due to impaired angiogenesis, persistent inflammation, and elevated oxidative stress, creating a substantial clinical and economic burden and highlighting the need for advanced extracellular matrix-mimicking dressings. Therefore, we have d...

Giriraj Pandey, Tejaswini Kolipaka, Deepankar Yadav et al. · 0 citations
Review Oct 2026

Hyaluronic acid-navigated nanoplatforms for oral cancer management: Current advances, translational perspectives, and future outlook-A review.

Oral cancer represents a significant global health burden exacerbated by aggressive tumor behavior and inadequate therapeutic outcomes, collectively contributing to high morbidity and mortality rates. Current treatment modalities, including surgery, radiotherapy, and chemotherapy, are often limited by a lack of tumor s...

Bishal Samadder, Suraj S. Wagh, Giriraj Pandey et al. · 0 citations
Review Sep 2026

Cell targeting peptide guided nanomedicine: a new paradigm in precision oncology for the management of non-small cell lung cancer.

The current review elucidates the pathophysiological complexity of NSCLC and prominent overexpressed receptors that can be harnessed for peptide-mediated targeting while critically evaluating the applications of CTP-functionalized NCs in chemotherapy, immunotherapy, phototherapy, gene delivery and tumor imaging.

Prerana Shetty, Shalini Shukla, Vivek Phatale et al. · 0 citations
Jul 2026

Intranasal Delivery of Piceatannol-Loaded Liposomes for Glioblastoma Management: Formulation Optimization, In Vitro, Ex Vivo, In Ovo and LC-MS/MS- Based In Vivo Pharmacokinetic and Brain Distribution Assessment

Overall, this research establishes PIC-LPO as a safe, non-invasive, and effective strategy to enhance brain delivery and antiangiogenic therapy, highlighting the translational potential of PIC for GBM management.

Anupama Sikder, Shraddha Naresh Katarpawar, Vivek Phatale et al. · 0 citations

Rational Coformer Screening of Multicomponent Crystals of Abiraterone Acetate Using Machine Learning (ML) and Multicomponent Hydrogen Bond Propensity (MCHBP): A Comprehensive Structural and Computational Investigation

Multicomponent crystalline systems offer a viable approach to improving the physicochemical and pharmacokinetic properties of drugs, thereby enabling the rational optimization of solid forms through coformer identification. The conventional process relies on empirical knowledge and chemical intuition. To overcome tra...

K. Potla, Abhishek Sharma, Hemanth Kongara et al. · 0 citations
Review Aug 2026

Unlocking exosome potential: Comprehensive review on diagnostic, prognostic and therapeutic approaches in melanoma.

Exosome-based strategies hold substantial potential for improving the diagnosis and management of melanoma, which may encourage the development of next-generation therapeutic interventions in the medical world.

Aashi Srivastava, Pooja Khairnar, Pallavi Chaure et al. · 0 citations
Aug 2026

Intranasal Pacritinib-loaded nanoemulsion for Glioblastoma management: In Vitro, ex Vivo, 3D spheroid and In vivo brain biodistribution studies.

It can be concluded that PAC-NE is a non-invasive delivery system which shows promising results for better brain delivery thereby supporting the clinical translation of PAC for GBM therapy.

Anupama Sikder, Shraddha Naresh Katarpawar, Vivek Phatale et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.